Mann Eye Institute
Houston, Texas, 76134-2099, United States
NCT Number: NCT06550375
This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.
Looking for future studies?
Notify Me50 year and older
All sexes
Observational
Houston, Texas, 76134-2099, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Implantation with the TECNIS Odyssey IOL
Time frame: 3 months postoperative
Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Time frame: 3 months postoperative
Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Time frame: 3 months postoperative
Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Time frame: 3 months postoperative
Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected
Time frame: 3 months postoperative
The AIOLIS has 37 questions about symptoms, perceptions of general vision, and frequency of wearing glasses or contact lenses. Perceptions about general vision are asked on a 5 item scale (Poor, Fair, Good, Very good, Excellent). Poor is considered a worse outcome.
Looking for future studies?
Notify MeMann Eye Institute
Other
Ambispective Analysis of Patient Reported Outcomes and Visual Acuity in Patients With Bilateral Implantation of Odyssey Intraocular Lenses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07840885
Cataract, Eye Diseases
Cape Coral, Florida, United States
View Trial DetailsNCT05157113
Behavior, Cataract
San Francisco, California, United States
View Trial DetailsNCT07246915
Age-related Cataract, Cataract
Bucharest, Romania
View Trial DetailsNCT06002399
Cataract, Eye Diseases
Brussels, Brussel Hoofdstedelijk Gewest, Belgium
View Trial Details